Bristol-Myers Squibb

Double-Digit Upside For Merck, Mylan Tops BioPharma
Seeking Alpha
Mon, 04/30/12 - 10:00 pm
Mylan
Merck
Bristol-Myers Squibb
Come On, Amylin, Just a Little Clue?
Motley Fool
Sat, 04/28/12 - 12:26 pm
Amylin
Bristol-Myers Squibb
M&A
The Drama Continues At Amylin Pharmaceuticals: Takeover Still Likely
Seeking Alpha
Fri, 04/27/12 - 10:16 am
Amylin
M&A
Bristol-Myers Squibb
Sanofi
Eli Lilly
Bristol-Myers Q1 profit up 12 pct. as sales rise
Yahoo/AP
Thu, 04/26/12 - 09:28 am
earnings
Bristol-Myers Squibb
Vertex Is Ready To Rise On INCIVEK Success
Seeking Alpha
Wed, 04/25/12 - 03:38 pm
Incivek
Vertex
hepatitis C
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Bristol-Myers Squibb: Earnings Preview
Seeking Alpha
Tue, 04/24/12 - 11:19 am
earnings
Bristol-Myers Squibb
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com
Tue, 04/24/12 - 10:36 am
cystic fibrosis
Vertex
Gilead
Bristol-Myers Squibb
Indenix
Kalydeco
VX-809
Earnings Preview: Bristol-Myers
Yahoo/Zacks
Mon, 04/23/12 - 10:33 am
Bristol-Myers Squibb
earnings
Amylin reportedly hires advisors to find a buyer
Marketwatch
Mon, 04/23/12 - 09:42 am
Amylin
M&A
Bristol-Myers Squibb
Gilead, Bristol Shine at EASL Conference
Motley Fool
Sun, 04/22/12 - 12:02 pm
Gilead Sciences
Bristol-Myers Squibb
GS-7977
daclatasvir
hepatitis C
Celebrate the Hep C Wins, for Now
Motley Fool
Sat, 04/21/12 - 12:26 pm
hepatitis C
Gilead Sciences
GS-7977
daclatasvir
Bristol-Myers Squibb
Abbott Laboratories
Vertex Pharmaceuticals
Incivek
Partner Up or Get Passed Up
Motley Fool
Sat, 04/21/12 - 11:51 am
GS-7977
Vertex Pharmaceuticals
hepatitis C
Roche
Bristol-Myers Squibb
Merck
Gilead Sciences
JNJ
Human Genome Sciences: Analyzing The Road Ahead Now That It Is In Play
Seeking Alpha
Fri, 04/20/12 - 10:51 am
Human Genome Sciences
Abbott Laboratories
Amgen
Amylin
Bristol-Myers Squibb
GSK
JNJ
Illumina
Merck
M&A
EU agency endorses Bristol, Astra diabetes drug
Reuters
Fri, 04/20/12 - 10:37 am
Europe
Bristol-Myers Squibb
AstraZeneca
diabetes
Bristol-Myers' Daclatasvir, Asunaprevir Cured 77%: Study
Bloomberg
Thu, 04/19/12 - 01:03 pm
daclatasvir
asunaprevir
Bristol-Myers Squibb
hepatitis C
Gilead Rises After Hepatitis Data Open New Test Options
Bloomberg
Thu, 04/19/12 - 11:43 am
hepatitis C
Gilead
Bristol-Myers Squibb
GS-7977
Bristol-Myers shares likely to pull back after conference, says MKM Partners
The Fly on the Wall
Thu, 04/19/12 - 11:42 am
Bristol-Myers Squibb
AstraZeneca Will Tumble If New Dutoprol Drug Fails
Seeking Alpha
Thu, 04/19/12 - 10:58 am
AstraZeneca
Dutoprol
Amgen
Bristol-Myers Squibb
GSK
Merck
Targacept
antihypertensives
Medivir Announces TMC435 in an Expanded Clinical Collaboration
Yahoo
Wed, 04/18/12 - 09:14 am
Medivir
TMC435
Janssen
Bristol-Myers Squibb
daclatasvir
hepatitis C
Vertex: Watch New Hepatitis C Drug
Seeking Alpha
Wed, 04/11/12 - 11:46 am
hepatitis C
Vertex
Incivek
Abbott Laboratories
Bristol-Myers Squibb
Gilead

Pages